<?xml version="1.0" encoding="UTF-8"?>
<p>E-30 (102/295; 34.6%) and E-6 (95/295; 32.2%) were the most frequently detected serotype from the EV-positive patients (
 <xref ref-type="fig" rid="viruses-11-00690-f003">Figure 3</xref>B). In spite of the higher incidence of the E-6 and E-30 serotypes during the years 2013 (15/20; 75%), 2014 (64/81; 79%), 2016 (31/39; 79.5%) and 2017 (63/73; 86.3%) (
 <xref ref-type="fig" rid="viruses-11-00690-f003">Figure 3</xref>A), 2015 did not show a high prevalence for these serotypes. Instead, we verified a more regular distribution throughout of the year of many serotypes, such as CV-B5, E-6, E-7, E-11, E-18 and E-30 (
 <xref ref-type="fig" rid="viruses-11-00690-f003">Figure 3</xref>A).
</p>
